Accessibility Menu
Absci logo

Absci

(NASDAQ) ABSI

Current Price$8.43
Market Cap$1.31B
Since IPO (2021)-61%
5 YearN/A
1 Year+201%
1 Month+65%

Absci Financials at a Glance

Market Cap

$1.31B

Revenue (TTM)

$1.84M

Net Income (TTM)

-$118.44M

EPS (TTM)

-$0.83

P/E Ratio

-10.13

Dividend

$0.00

Beta (Volatility)

2.30 (High)

Price

$8.43

Volume

327

Open

$7.47

Previous Close

$8.43

Daily Range

$7.47 - $8.56

52-Week Range

$2.24 - $8.57

Estimated Earnings Date

Aug 18, 2026

ABSI: Motley Fool Moneyball Superscore

54

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Absci

Industry

Biotechnology

Employees

140

CEO

Sean McClain

Headquarters

Vancouver, WA 98683, US

ABSI Financials

Key Financial Metrics (TTM)

Gross Margin

-13%

Operating Margin

-70%

Net Income Margin

-65%

Return on Equity

-64%

Return on Capital

-73%

Return on Assets

-61%

Earnings Yield

-9.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.31B

Shares Outstanding

155.91M

Volume

327

Avg. Volume

4.94M

Financials (TTM)

Gross Profit

-$8.94M

Operating Income

-$124.72M

EBITDA

-$103.16M

Operating Cash Flow

-$92.93M

Capital Expenditure

-$1.11M

Free Cash Flow

-$94.03M

Cash & ST Invst.

$144.29M

Total Debt

$5.30M

Absci Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$215.00K

-81.8%

Gross Profit

-$2.51M

+83.5%

Gross Margin

-11.69%

N/A

Market Cap

$1.31B

N/A

Market Cap/Employee

$8.39M

N/A

Employees

156

N/A

Net Income

-$29.60M

-12.3%

EBITDA

-$26.87M

-15.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$125.71M

-6.2%

Total Debt

$4.42M

-50.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$2.15M

-54.2%

Short Term Debt

$2.27M

-46.4%

Return on Assets

-60.55%

N/A

Return on Invested Capital

-73.21%

N/A

Free Cash Flow

-$26.34M

-20.5%

Operating Cash Flow

-$26.31M

-20.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MGTXMeiraGTx Holdings plc
$11.48+1.41%
CRVSCorvus Pharmaceuticals, Inc.
$12.56+5.46%
VTYXVentyx Biosciences, Inc.
$14.00+0.00%
MLTXMoonLake Immunotherapeutics
$22.16+15.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$36.93+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$82.58-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.37+0.02%
KEELKeel Infrastructure
$6.66+0.06%

Questions About ABSI

What is the current price of Absci?

Absci is trading at $8.43 per share.

What is the 52-week range for Absci?

Over the past 52 weeks, Absci has traded between $2.24 and $8.57.

How much debt does Absci have?

As of the most recent reporting period, Absci reported total debt of $4.42M.

How much cash does Absci have on hand?

Absci reported $8.63M in cash and cash equivalents in its most recent financial results.

What is Absci’s dividend yield?

Absci does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.